HOME         WEBSITE         SUBSCRIBE           E-GREETINGS   
                               

Tuesday, March 08, 2011

Weekly Scenario: Equity Funds Gain

Renewed FII buying along with short covering post the Union Budget helped Indian equity markets bounce back from recent lows and close the week ended 4 March 2011 on a strong note. Market sentiments were also boosted by some easing in international oil prices. Mid and Small cap stocks continued to underperform large caps. Among the major categories in equity funds, Index Funds and Large Cap Funds were the highest gainers by 4.22% and 4.08% respectively over the one week period ended 4 March 2011. It was followed by Tax Saving Funds by 3.62%, Multi Cap Funds by 3.57% and Mid Cap Funds by 2.98% 

Indian bond markets gained as the fiscal deficit and borrowing projections for FY12 came in below market expectations. Further easing in primary article inflation index levels also aided sentiment. Among the debt fund categories, Gilt Fund – Medium & Long Term gained the highest by 0.27%, followed by Gilt Funds – Short Term by 0.22%, Income Funds by 0.20%, Floating Rate Income Funds – Long Term by 0.18%, Short Term Income Funds by 0.17%, Floating Rate Income Funds – Short Term, Ultra Short Term Funds and Liquid Funds by 0.15% each. 

Equity Diversified Funds
 
Large Cap Funds: Among the schemes in the large cap funds, JM Equity Fund gained the maximum of 4.80%, followed by Morgan Stanley Growth Fund which climbed by 4.64%, BNP Paribas Equity Fund and L&T Hedged Equity Fund jumped 4.55% each among others. Escorts Growth Plan and Reliance NRI Equity Fund ended at the bottom this category gaining by 1.87% and 2.66% respectively. 

Mid Cap Funds: HSBC Midcap Equity Fund was the top performer, which gained by 5.15%, followed by Sundaram Equity Multiplier which climbed 4.43% and JM Mid Cap fund rose 4.40% among others. Axis Midcap Fund and ICICI Pru Emerging S.T.A.R Fund ended at the bottom of this category gaining by 0.30% and 1.08% respectively. 

Multi Cap Funds: Bharti AXA Equity Fund was the top performer, which gained 5.03%, followed by Bharti AXA Equity Fund - Eco which climbed 5% and Axis Equity Fund rose 4.75% among others. Edelweiss Absolute Return Fund and Birla Sun Life India Opportunities Fund – B were the schemes to deliver lower returns in this category gaining by just 0.09% and 1.78% respectively. 
 
Tax Savings Funds
 
Bharti AXA Tax Advantage Fund - Eco and Bharti AXA Tax Advantage Fund were the top performers with a return of 4.98% and 4.96% respectively during one week period. Among the other schemes in the category, L&T Tax Saver Fund rose 4.80%, Axis Tax Saver Fund climbed 4.49% and Baroda Pioneer ELSS ‘96 surged 4.33%. Escorts Tax Plan and ICICI Pru Tax Plan were the schemes to deliver lower returns in this category gaining by just 1.67% and 1.98% respectively. 

Index Funds
 
The NAV of Index Fund category advanced by 4.22% over one week period with Principal Index Fund being the top gainer with a return of 4.42%. It was followed by Tata Index Fund - Sensex Plan and LICMF Index Fund - Nifty Plan with 4.41% each. HDFC Index Fund-Sensex Plus Plan and ICICI Pru Nifty Junior Index Fund ended at the bottom of this category posting weekly returns of 3.11% and 3.64% respectively. 

Sector Funds
 
Banking Funds category gained 5.06%, with JM Financial Services Sector Fund gaining 5.75% and Sundaram Financial Services Opportunities gaining by 5.24% among others. Sahara Banking & Financial Services Fund ended at the bottom of this category with a return of 4.59%. 

FMCG Funds category gained 4.08% over one week period ended 4 March 2011. SBI Magnum SFU - FMCG Fund and ICICI Pru FMCG Fund were the top gainer in this category. Their NAV appreciated by 5.03% and 3.74% respectively over one week period. 

NAV of Pharma Funds category advanced 1.63%, with UTI-Pharma & Healthcare Fund ending the week as the biggest gainer with an increase in NAV by 2.01%; it was followed by Reliance Pharma Fund which gained 1.74%. 

Infotech Funds category gained 1.60% over one week period ended 4 March 2011. SBI Magnum SFU – Infotech Fund was the top gainer with a return of 1.95%. 

Hybrid Funds
 
UTI-CCP Advantage Fund and ING Balanced Fund were the highest gainer in equity oriented balanced fund category with their NAV appreciating by 3.51% and 3.29% respectively. Principal SMART Equity Fund, ICICI Pru Equity & Derivative – Wealth Optimizer and ICICI Pru Child Care Plan-Gift Plan were the worst performer in this category gaining by 1.46%, 1.51% and 1.63% respectively. 

LICMF Children's Fund was the highest gainer in debt oriented balanced fund category as its NAV appreciated by 2.42%. Tata Young Citizens Fund was the next highest gainer by 1.84%. Escorts Income Bond and DWS Money Plus Advantage Fund were the worst performers in this category gaining by 0.11% each.

Blog Archive

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.


In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.


Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.


Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.


Published Credits goes to following sources & all the mentioned sources as footer below the published material- Bloomberg, Valueresearch Online, Capital Market, Navindia, Franklin Templeton, Kitco, SBI AMC, LIC AMC, JM Financial AMC, HDFC AMC, The Hindu, Business Line, Personal FN, Economic Times, Reuters, Outlook Money, Business Standard, Times of India etc.